Compare Our Tests | Foundation Medicine
Automated next-generation profiling of genomic alterations in human cancers | Nature Communications
Foundation Medicine's cancer genomics test - Enseqlopedia
Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA - ScienceDirect
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
Foundation Medicine
When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine
When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine
Companion Diagnostics Explained: Their Critical Role in Cancer Care and Our Latest Approvals | Foundation Medicine
FoundationOne CDx
Survey of Precision Oncology Programs Finds Agreement on Testing, Divergence in Care Delivery | Precision Oncology News
FoundationOne® CDx Cancer Genomic Profile Product Overview
FoundationOne CDx
Next generation sequencing‐based gene panel tests for the management of solid tumors - Nagahashi - 2019 - Cancer Science - Wiley Online Library
FoundationOne CDx Wins National Coverage Decision Across All Solid Tumors
Foundation medicine Comprehensive Genomic Profiling Brochure
Foundation Medicine's cancer genomics test - Enseqlopedia
FoundationOne® CDx Cancer Genomic Profile Product Overview
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors | PLOS ONE
Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors | Scientific Reports
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors | PLOS ONE
